I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 34% ± 12% | |
| adipocyte | 10 studies | 58% ± 18% | |
| mast cell | 10 studies | 38% ± 14% | |
| type I pneumocyte | 8 studies | 27% ± 8% | |
| glutamatergic neuron | 8 studies | 32% ± 18% | |
| astrocyte | 8 studies | 31% ± 15% | |
| GABAergic neuron | 7 studies | 41% ± 13% | |
| interneuron | 6 studies | 40% ± 26% | |
| neuron | 6 studies | 38% ± 19% | |
| epithelial cell | 6 studies | 38% ± 16% | |
| retinal cone cell | 6 studies | 35% ± 12% | |
| fibroblast | 6 studies | 31% ± 10% | |
| vein endothelial cell | 5 studies | 45% ± 24% | |
| ciliated cell | 5 studies | 33% ± 11% | |
| goblet cell | 5 studies | 46% ± 14% | |
| hematopoietic precursor cell | 4 studies | 26% ± 9% | |
| macrophage | 4 studies | 26% ± 7% | |
| microglial cell | 4 studies | 25% ± 6% | |
| cardiac muscle cell | 4 studies | 25% ± 4% | |
| type II pneumocyte | 4 studies | 24% ± 5% | |
| dendritic cell | 4 studies | 21% ± 6% | |
| natural killer cell | 4 studies | 21% ± 5% | |
| club cell | 4 studies | 26% ± 6% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 20% ± 4% | |
| capillary endothelial cell | 3 studies | 24% ± 7% | |
| retinal bipolar neuron | 3 studies | 16% ± 0% | |
| GABAergic interneuron | 3 studies | 20% ± 2% | |
| granule cell | 3 studies | 35% ± 8% | |
| progenitor cell | 3 studies | 27% ± 13% | |
| mesothelial cell | 3 studies | 21% ± 5% | |
| lymphocyte | 3 studies | 25% ± 6% | |
| OFF-bipolar cell | 3 studies | 19% ± 4% | |
| retinal rod cell | 3 studies | 24% ± 6% | |
| endothelial cell of lymphatic vessel | 3 studies | 20% ± 3% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 35% ± 8% | |
| enteroendocrine cell | 3 studies | 36% ± 12% | |
| basal cell | 3 studies | 42% ± 22% | |
| brush cell | 3 studies | 24% ± 6% | |
| erythroblast | 3 studies | 34% ± 6% |
